The Role of MAP Kinase in The Signal Transduction Pathways Activated by Mechanical Stress in Mesenchymal Cells.
MAP 激酶在间充质细胞机械应力激活的信号转导途径中的作用。
基本信息
- 批准号:09672094
- 负责人:
- 金额:$ 2.05万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Studies on interleukin-6 (IL-6) in bone metabolism in response to mechanical stress have been accumulating. However, its effects on osteoblasts are still unclear because the results are conflicting depending on the study models employed. We reasoned that these conflicting data are due to variable expression levels of membrane-bound IL-6 receptors (IL-6Rs). In the present study, we found that IL-6 in combination with soluble IL-6R (sIL-6R) consistently caused a marked elevation of alkaline phosphatase and a decrease in proliferation in the human osteoblastic cell line MG-63, which expressed no detectable membrane-bound IL-6R and failed to respond to IL-6. These effects of IL-6/sIL-6R were blocked by neutralizing antibodies to the IL-6 signal transducer gp 130, suggesting an involvement of IL-6 signaling in the elicitation of the effects of IL-6/sIL6R.Upon stimulation with IL-6/sIL-6R, the gp 130, cytoplasmic Janus kinases JAK1 and JAK2 were tyrosine phosphorylated. Moreover, signal transducers and activators of transcription STAT1 and STAT3 were also tyrosine phosphorylated, translocated to the nucleus, and bound to the putative STAT-binding DNA elements. In addition, mitogen-activated protein (MAP) kinase was also activated in response to IL-6/sIL-6R.These data demonstrate that sIL-SR may enhance the responsiveness of MG-63 cells to IL-6. Thus, IL-6 in collaboration with sIL-6R may modulate differentiation and proliferation of osteoblastic cells, presumably by activating two distinct signaling pathways of JAK-STAT and MAP kinase.
关于白细胞介素 6 (IL-6) 在骨代谢中响应机械应力的研究不断积累。然而,它对成骨细胞的影响仍不清楚,因为根据所采用的研究模型,结果是相互矛盾的。我们推断这些相互矛盾的数据是由于膜结合 IL-6 受体 (IL-6R) 的表达水平不同所致。在本研究中,我们发现 IL-6 与可溶性 IL-6R (sIL-6R) 组合一致导致人成骨细胞系 MG-63 中碱性磷酸酶显着升高和增殖减少,该细胞系未检测到表达膜结合 IL-6R,对 IL-6 没有反应。 IL-6/sIL-6R 的这些作用被 IL-6 信号转导器 gp 130 的中和抗体阻断,表明 IL-6 信号传导参与了 IL-6/sIL6R 作用的引发。 -6/sIL-6R、gp 130、细胞质 Janus 激酶 JAK1 和 JAK2 被酪氨酸磷酸化。此外,转录STAT1和STAT3的信号转导子和激活子也被酪氨酸磷酸化,转移到细胞核,并与假定的STAT结合DNA元件结合。此外,丝裂原激活蛋白(MAP)激酶也响应IL-6/sIL-6R而被激活。这些数据表明sIL-SR可以增强MG-63细胞对IL-6的反应性。因此,IL-6 与 sIL-6R 协同作用可能通过激活 JAK-STAT 和 MAP 激酶这两个不同的信号通路来调节成骨细胞的分化和增殖。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
K.Moriyama et al.: "Transactions,8th International Congress on Cleft Palate and Related Craniofacial Anomalies" S.T.Lee,Stamford Press Pte Ltd,Singapore, 1066 (1997)
K.Moriyama 等人:“交易,第八届腭裂和相关颅面异常国际大会”S.T.Lee,Stamford Press Pte Ltd,新加坡,1066 (1997)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
R.Nishimura et al.: "Combination of Interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-Stat and MAP kinase pathways in MG-63 human osteoblastic osteosarcoma cells." J.Bone and Mineral Res.13・5. 777-785 (1998)
R. Nishimura 等人:“白细胞介素 6 和可溶性白细胞介素 6 受体的组合可诱导 MG-63 人成骨细胞骨肉瘤细胞中 JAK-Stat 和 MAP 激酶途径的分化和激活,J.Bone and Mineral Res.13・” 5.777-785(1998)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
N.funato et al.: "Evidence for apoptosis sigulating kinase(ASK)1 in the regenerating palatal epithelium upon acute injury." Lab.Invest.78・4. 477-483 (1998)
N.funato 等人:“急性损伤后腭上皮细胞凋亡调节激酶 (ASK)1 的证据。Lab.Invest.78·4 (1998)”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
N.Funato, et al: "Evidence for apoptosis signal-regulating kinase(ASK)1 in the regenerating palatal epithelium upon acute injury." Laboratory Investigation. (in press). (1998)
N.Funato 等人:“急性损伤后腭上皮再生中凋亡信号调节激酶 (ASK)1 的证据。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
M.Yokozeki et al.: "Interferon-γ inhibits the myofibroblastic phenotype of rat palatal fibroblasts induced by transforming growth factor-β1 in vitro." FEBS Letters. 442・1. 61-64 (1999)
M. Yokozeki 等人:“干扰素-γ 抑制体外转化生长因子-β1 诱导的大鼠腭成纤维细胞表型。” FEBS Letters 61-64 (1999)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MORIYAMA Keiji其他文献
MORIYAMA Keiji的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MORIYAMA Keiji', 18)}}的其他基金
Elucidation of etiology of facial asymmetry based on integrated genome-phenome analysis
基于综合基因组-表型分析阐明面部不对称的病因
- 批准号:
19H03857 - 财政年份:2019
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
International comparative study on craniofacial morphology of Mongolian adolescents
蒙古族青少年颅面形态的国际比较研究
- 批准号:
25305037 - 财政年份:2013
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of new technology for controlling suture remodeling using magnetized liposome with liposome
脂质体磁化脂质体控制缝线重塑新技术的开发
- 批准号:
23659963 - 财政年份:2011
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Development of new therapeutic strategy for the craniosynostosis patients
颅缝早闭患者新治疗策略的开发
- 批准号:
23390471 - 财政年份:2011
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Basic study for developing new therapies and its practical use for craniofacial anomalies
颅面异常新疗法开发及其实际应用的基础研究
- 批准号:
18209060 - 财政年份:2006
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Mechanism of bone destruction due to Rheumatoid Arthritis in the fields of Osteoimmunology
骨免疫学领域类风湿关节炎引起的骨破坏机制
- 批准号:
15390637 - 财政年份:2003
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The function of periostin during periodontal tissue remodeling caused by mechanical stress.
骨膜素在机械应力引起的牙周组织重塑过程中的功能。
- 批准号:
13470452 - 财政年份:2001
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Establishment of new treatment for cleft lip and palate patients-basic research for the application of in vitro hybrid artificial bone-
唇腭裂患者新疗法的建立——体外混合型人工骨应用基础研究——
- 批准号:
12557185 - 财政年份:2000
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
REGULATION OF OSTEOCLASTIC BONE RESORPTION BY RHO
RHO 对破骨性骨吸收的调节
- 批准号:
11694283 - 财政年份:1999
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
相似国自然基金
基于IL-6调控Th17/Treg细胞平衡探究复方青娥丸通过重塑骨免疫微环境治疗绝经后骨质疏松症的作用机制
- 批准号:82374491
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
靶向软骨下骨衰老细胞及其衰老相关IL-6分泌表型治疗骨性关节炎的相关机制研究
- 批准号:82302740
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
IL-6和PD-1抗体联用对KRAS突变肺腺癌的治疗作用及机制研究
- 批准号:82303747
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
IL-6/MUL1调控STING泛素化抑制肝内胆管癌免疫应答的机制研究及干预新方案探索
- 批准号:82373323
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
肠道菌群失衡通过TLR4/IL-6信号通路触发膝关节骨性关节炎的发病机制研究
- 批准号:82302769
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigation of the anti-inflammatory mechanism of beta2 adrenergic receptor-IL-6 axis activation
β2肾上腺素受体-IL-6轴激活的抗炎机制研究
- 批准号:
19K07118 - 财政年份:2019
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Roles for CD157 in functions of macrophage lineage cells and early pathophysiology of a rheumatoid arthritis model
CD157 在巨噬细胞谱系细胞功能和类风湿关节炎模型早期病理生理学中的作用
- 批准号:
17K08798 - 财政年份:2017
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The detrimental effect of soluble IL-6 receptor on CD4 T cell-mediated anti-tumor immune responses
可溶性 IL-6 受体对 CD4 T 细胞介导的抗肿瘤免疫反应的有害影响
- 批准号:
26430165 - 财政年份:2014
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
歯周炎における可溶性IL-6受容体の新たな臨床マーカーとしての可能性の検索
寻找可溶性IL-6受体作为牙周炎新临床标志物的可能性
- 批准号:
18791590 - 财政年份:2006
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
New strategic approach to develop therapeutic agent for diabetic retinopathy by regulation of apoptosis of retinal vascular cells and neurons
通过调节视网膜血管细胞和神经元凋亡来开发糖尿病视网膜病变治疗剂的新战略方法
- 批准号:
14571656 - 财政年份:2002
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)